Kojic Acid vs Tranexamic Acid

Kojic Acid: May help uneven pigmentation, often as part of a combination treatment. Tranexamic Acid: Topical formulas are studied for melasma, with mixed results.

Research updated 2026-10-25
Five kojic acid products on white, including a turmeric serum, Medicube capsule cream, Admire My Skin and Seoul CeuticalsFive serums lined up on white, labeled tranexamic acid or niacinamide with TXA, including SkinCeuticals Discoloration Defense

Which one is right for you?

Choose Kojic Acid if…

Consider for uneven pigment if tolerated; evidence is mainly for combinations.

  • Mild uneven tone
  • Hydroquinone isn’t an option
  • You tolerate actives

Choose Tranexamic Acid if…

Consider a topical pigment option; the evidence is mixed and formula-specific.

  • Melasma or stubborn dark marks
  • Skin that dislikes hydroquinone
  • Daily sunscreen
Fine together

Can you use both?

A useful pairing for dark spots and melasma.

At a glance

● Kojic Acid
● Tranexamic Acid
Type
Pigment-targeting ingredient
Pigment-targeting ingredient
What it does
May help uneven pigmentation, often as part of a combination treatment.
Topical formulas are studied for melasma, with mixed results.
Best for
Melasma
Melasma
Studied concentrations
2% added to hydroquinone and glycolic acid in the cited melasma study.
Topical 5% in the cited trials; oral treatment is a separate medical decision.
When to use
On the schedule specified for the product or prescribed treatment.
On the schedule specified for the product or prescribed treatment.
Time to results
Usually assessed over 8–16 weeks
Usually assessed over 8–16 weeks
Irritation
Can cause stinging, redness or contact dermatitis.
Can sting or cause redness; do not substitute tablets or injections for a cosmetic product.
Sensitive skin
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Available
Prescription or cosmetic status depends on the active, formula and country; check the label.
Prescription or cosmetic status depends on the active, formula and country; check the label.

What it helps

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Kojic Acid
Tranexamic Acid
Limited evidenceEarly or small studies
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

Adding 2% kojic acid improved results in a small combination-treatment trial.
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

Trials report mixed results, including one with no clear benefit over vehicle.
Insufficient evidence
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trial does not establish an independent effect on post-acne marks.
AI-generated educational illustration of Sun Spots: 1. Sun Spots Header — Light Skin; Lighter skin. Not a clinical photograph.

Sun Spots

The reviewed sources do not establish this ingredient as a treatment for this concern.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Sensitive Skin on light skin.

Sensitive Skin

The reviewed sources do not establish this ingredient as a treatment for this concern.
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trials do not establish benefit for all post-inflammatory pigment.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Post-Inflammatory Redness.

Post-Inflammatory Redness

The reviewed sources do not establish this ingredient as a treatment for this concern.
A relaxed forehead with faint shallow horizontal fine lines.

Wrinkles and Fine Lines

The reviewed sources do not establish this ingredient as a treatment for this concern.
How it works

Kojic Acid

Kojic Acid mechanism diagram. Reduces tyrosinase activity: Kojic acid interferes with melanin production. Less new pigment forms: Effects depend on the formula and tolerance.
Open full-size diagram
Diagram explanation and sources

Reduces tyrosinase activity: Kojic acid interferes with melanin production. Less new pigment forms: Effects depend on the formula and tolerance.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1

Tranexamic Acid

Tranexamic Acid mechanism diagram. Affects plasmin-related signaling: May reduce signals that stimulate pigment production. May help uneven pigmentation: Delivery and the formula influence topical results.
Open full-size diagram
Diagram explanation and sources

Affects plasmin-related signaling: May reduce signals that stimulate pigment production. May help uneven pigmentation: Delivery and the formula influence topical results.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2

Using both in one routine

Built from where each one usually sits in a routine. Introduce one at a time.

Morning
Step 1
Cleanser
Step 2
Tranexamic AcidMorning or night
Step 3
Moisturizer
Step 4
Sunscreen
Night
Step 1
Cleanser
Step 2
Kojic AcidNight
Step 3
Tranexamic AcidMorning or night
Step 4
Moisturizer

Strengths and forms

Concentrations

Kojic acid concentrations in older studies differ from current cosmetic limits. In the EU, kojic acid is limited to 1% in face and hand products; that is not a universal treatment target.

1%

2%

EU cosmetic ceiling

The maximum in specified face and hand products. This is a regulatory limit, not proof of the best efficacy.

Older combination-study strength

Studied with hydroquinone and glycolic acid. The combination result does not isolate kojic acid or establish a current home-use recommendation.

Choosing a strength: Check local rules and the full formula. Kojic acid and kojic dipalmitate are different ingredients and cannot be compared by percentage alone.

Higher strengths: Do not use an older trial’s concentration as a reason to exceed current limits. Irritation or allergic contact dermatitis can occur.

Formula matters: Combination products may obtain benefit from several ingredients. A study of a combination cannot tell you what kojic acid alone contributed.

Topical tranexamic acid studies have used different delivery systems, including 1.8% liposomal lotion and 5% creams or solutions. Oral treatment and procedure-assisted delivery are separate medical decisions.

1.8%

5%

Studied liposomal lotion

One melasma trial tested this delivery system. Its percentage cannot be directly compared with an ordinary serum.

Studied topical formulas

Several melasma studies used topical formulas at this strength. Evidence does not establish one best concentration for all pigment concerns.

Choosing a strength: Look for evidence on the finished topical product. Do not use injectable or oral products as DIY skincare.

Higher strengths: A stronger topical percentage has not been shown to guarantee better results. Oral use requires separate evaluation of risks, including clotting risk.

Formula matters: Liposomal delivery, other brightening ingredients and procedures can change the treatment. A microneedling study is not evidence for the same result from a home serum.

Forms
Serum · Soap · Cream
Serum · Tablet · Injection

When you’ll see results

Approximate windows, not promises.

● Kojic Acid
● Tranexamic Acid
First few weeks

First few weeksAssess tolerance first; pigment change is usually slower.

First few weeksAssess tolerance first; pigment change is usually slower.

4–8 weeks

4–8 weeksSome studied regimens begin showing pigment improvement.

4–8 weeksSome studied regimens begin showing pigment improvement.

8–12 weeks

8–12 weeksA useful review point for benefit and irritation.

8–12 weeksA useful review point for benefit and irritation.

3–6 months

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

6–12 months

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

Safety and sensitive skin

Common reactions

Can cause stinging, redness or contact dermatitis.

Can sting or cause redness; do not substitute tablets or injections for a cosmetic product.

When to stop

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Sensitive or inflamed skin

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Important limits

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Pregnancy

There is not much pregnancy-specific data on kojic acid, and melasma often appears or worsens in pregnancy. Ask the doctor managing your pregnancy first. Azelaic acid and strict sun protection are the usual alternatives.

Melasma is common in pregnancy, so this comes up constantly. Oral tranexamic acid is not a casual pregnancy decision, and the topical version has little pregnancy-specific data. Ask the doctor managing your pregnancy, since they know your full picture.

How it works

In the skin

On the skin. The finished product delivers kojic acid in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Inhibits tyrosinase activity involved in melanin production; cosmetic formulas differ from studied combinations.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

On the skin. The finished product delivers tranexamic acid in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. May affect plasmin-related signalling involved in pigmentation; a small molecular size does not guarantee delivery.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

Getting in
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Molecule size
Kojic Acid · 142 Da
Tranexamic Acid · 157 Da
Smaller than 500 Da passes the outer skin more easily. Size isn’t an effectiveness score.
500 Da guideline

Product examples

Kojic Acid
  • Naturium Tranexamic Topical Acid — 5% tranexamic acid with kojic acid and niacinamide, for $20. Well built, and no serum fixes melasma alone.
  • MediCube Kojic Acid Turmeric Body Peel Shot
  • MediCube Kojic Acid Turmeric Peel Shot
Tranexamic Acid
  • Anua Dark Spot Correcting Serum — 10% niacinamide and 4% tranexamic acid — a well-chosen pair of pigment actives at a fair price.
  • Naturium Tranexamic Topical Acid — 5% tranexamic acid with kojic acid and niacinamide, for $20. Well built, and no serum fixes melasma alone.

Common questions

Kojic Acid:What should I choose kojic acid for?

Consider for uneven pigment if tolerated; evidence is mainly for combinations.

Kojic Acid:How strong is the evidence?

A 40-woman split-face trial added kojic acid to hydroquinone and glycolic acid. It does not show that kojic acid alone performs as well as the combination or that higher strengths are better.

Tranexamic Acid:What should I choose tranexamic acid for?

Consider a topical pigment option; the evidence is mixed and formula-specific.

Tranexamic Acid:How strong is the evidence?

A small vehicle-controlled 5% trial did not show superiority over vehicle. A larger active-comparator study found improvement in both groups but did not prove equivalence to hydroquinone.

Sources

Sources and further reading

  1. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. (1999)
  2. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. (2012)
  3. A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma. (2019)
  4. EU Regulation 2024/996: cosmetic concentration restrictions
  5. Trial of 1.8% liposomal and procedure-assisted tranexamic acid
  6. Randomized trial of topical 5% tranexamic acid
Dermapedia on YouTube